---
title: "LI - Jie — Ownership Dossier"
canonical: https://whiteintel.dev/entity/23fd0e5c-e6e6-5357-93aa-953275bc5add
json: https://whiteintel.dev/api/public/dossier/23fd0e5c-e6e6-5357-93aa-953275bc5add
identifier: icij:icijol-80093506
jurisdiction: CN
risk: Low
source: WhiteIntel corporate-ownership graph
---

# LI - Jie

**Type:** Organization  
**Jurisdiction:** CN  
**Identifier:** `icij:icijol-80093506`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/23fd0e5c-e6e6-5357-93aa-953275bc5add  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/23fd0e5c-e6e6-5357-93aa-953275bc5add  

## Ownership & control

### Holdings / subsidiaries

- **China Biotech Pharmaceutical Company Limited** (director of) — https://whiteintel.dev/entity/bbd21b0a-c4c1-5de2-9a7e-36d2beda586a

## Provenance

- ICIJ Offshore Leaks — https://offshoreleaks.icij.org/nodes/80093506

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **LI - Jie**. Human view: https://whiteintel.dev/entity/23fd0e5c-e6e6-5357-93aa-953275bc5add · Structured JSON: https://whiteintel.dev/api/public/dossier/23fd0e5c-e6e6-5357-93aa-953275bc5add._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._